Non-melanoma skin cancer: what drives tumor development and progression?
about
Protection of normal human reconstructed epidermis from UV by catalase overexpressionIdentification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinomaThe role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesisThe relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursorsDeciphering the role of nuclear and cytoplasmic IKKα in skin cancerSafety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis.Characterization of novel cutaneous human papillomavirus genotypes HPV-150 and HPV-151.A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients.PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomasGiant desmoplastic cutaneous squamous cell carcinoma of the gluteal region.Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts.Targeted inhibition of BRAF kinase: opportunities and challenges for therapeutics in melanoma.Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.Differential roles of T-cell subsets in regulation of ultraviolet radiation induced cutaneous photocarcinogenesis.Opposing roles for calcineurin and ATF3 in squamous skin cancer.Occupational exposure to ultraviolet radiation and risk of non-melanoma skin cancer in a multinational European studyUnbiased approach for virus detection in skin lesions.High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patientsSkin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.Genomic instability in human actinic keratosis and squamous cell carcinoma.Chromatin Memory in the Development of Human CancersRegulation of ultraviolet radiation induced cutaneous photoimmunosuppression by toll-like receptor-4UVA and UVB irradiation differentially regulate microRNA expression in human primary keratinocytes.Roles of the immune system in skin cancer.A humanized stromal bed is required for engraftment of isolated human primary squamous cell carcinoma cells in immunocompromised mice.From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.Next-generation sequencing of the basal cell carcinoma miRNome and a description of novel microRNA candidates under neoadjuvant vismodegib therapy: an integrative molecular and surgical case study.Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma.Viruses in case series of tumors: Consistent presence in different cancers in the same subjectThe mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint.Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinomaMicroarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genesExpression patterns of α2,3-sialyltransferase I and α2,6-sialyltransferase I in human cutaneous epithelial lesions.MYC in mammalian epidermis: how can an oncogene stimulate differentiation?Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish.Nonmelanoma skin cancer and risk for subsequent malignancy.
P2860
Q24307849-94444C37-8A7A-4832-8008-F11050C5CCCDQ24609306-E42D0F58-B819-4E4F-87F4-B963BFF1764FQ24626306-046D7306-47D5-4753-AE2E-6052DB01C363Q26775913-45126FCD-2ABC-44D7-A3A9-8D899A59B096Q28828173-FD3B83FB-BC2A-4BF6-BCBB-C014BC107D2DQ30577671-7712994A-2A04-4ECD-A053-CD8517EA72E1Q31028241-44DE3F2F-E2BF-40D5-B55B-CD966166DC15Q33584310-2E3735B4-0FA5-4255-8B06-9BAEFAB2A800Q33614767-D33B1FC6-6F85-4B43-BE65-0768372C5F40Q33693105-BF6F71D2-C005-483E-9ADD-7EB535C532B2Q33816432-59FD332B-D1E0-49D4-9E30-1DC292E2429BQ33870083-B301125A-73CD-4968-BA85-41C04E3EFA62Q33891095-8DE305FC-D48F-432A-8F84-C0F948F95A85Q34222257-165736F0-A6C3-44DD-B6FC-662E146FA424Q34573854-37D92A99-5EE4-4446-A785-A6160A8FBD32Q34629730-2CD7A121-A5A9-4314-99DC-8A3A414CECEBQ34632548-2AD6EC0C-C5F2-465F-BB67-D1B71DD3C2A1Q34701297-252D50F8-27D5-4BDB-8AA6-D27E46CB6DCBQ34804828-12BB15EE-A014-4568-8993-B5D1D7A588DCQ34806867-B4C83C70-0032-4968-80F6-0CF0602A891BQ34958801-CFA0453D-18B7-49CD-B5CC-4382D1A07D83Q34978705-C67CF75F-1627-4E0E-A7E5-52908AA391B9Q34979975-94A317F8-7C9D-4427-AB64-2E970E3DFF24Q35046979-55B0B17E-735B-4434-B7EF-96DFC17C3F38Q35082450-8AFD47D0-C34A-44E0-8D29-5B178CF01BA8Q35403714-F8882042-B8CF-41D5-874C-1EB8E5221215Q35659439-F3B7F623-6712-41E3-B819-C73DE7401FD4Q35698913-31A02362-2D05-4788-B36F-0D3900C3A8B3Q35721081-B92CE8EE-C109-46C0-AD7A-E78525680F9CQ35844631-CC2F77D6-2060-45DF-A8CA-825D58FF796EQ36078222-2AD370B6-5F9C-4168-A70E-E0046A2B4126Q36296702-3E507E01-3843-4D97-9D74-0A8CA67A23F1Q36581649-E28FDDAF-50A4-4AD1-BD8F-AC1B22C9EE8AQ36587639-71EDCAD7-74CD-4BFD-AAD7-CC54F72D4B45Q36765030-AF0299F3-F732-40CB-B817-6DC1F3CC50CCQ36931879-5CC9ACAC-56A8-417F-B419-24B045F4F7A8Q37091735-FFE1E6DB-6F11-49AE-8496-204C8DDC80B3Q37199591-857273D2-2C1B-4ED7-80A1-D2628550ED1DQ37262785-34190D90-D5A4-465C-9221-6237F2FE6E34Q37288894-023EDA56-1DD1-40BA-AED8-623257C2A78E
P2860
Non-melanoma skin cancer: what drives tumor development and progression?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Non-melanoma skin cancer: what drives tumor development and progression?
@ast
Non-melanoma skin cancer: what drives tumor development and progression?
@en
type
label
Non-melanoma skin cancer: what drives tumor development and progression?
@ast
Non-melanoma skin cancer: what drives tumor development and progression?
@en
prefLabel
Non-melanoma skin cancer: what drives tumor development and progression?
@ast
Non-melanoma skin cancer: what drives tumor development and progression?
@en
P356
P1433
P1476
Non-melanoma skin cancer: what drives tumor development and progression?
@en
P2093
Petra Boukamp
P304
P356
10.1093/CARCIN/BGI123
P407
P577
2005-05-19T00:00:00Z